Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation

Bone Marrow Transplantation

Volumn 17, Issue 6, 1996, Pages 1051-1056

  DeVincenzo, J P ^a,c   Leombruno, D ^b   Soiffer, R J ^a   Siber, G R ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

BMT; Immunotherapy; Respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN; RIBAVIRIN;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THORAX RADIOGRAPHY; VIRUS PNEUMONIA;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030057423     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hall CB, Geiman JM, Biggard R et al. Respiratory syncytial virus infections within families. New Engl J Med 1976; 294: 414-419.
2. Englund JA, Sullivan CJ, Jordan MC et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988; 109: 203-208.
3. Hall CB, Powell KR, MacDonald NE et al. Respiratory syncytial viral infection in children with compromised immune function. New Engl J Med 1986; 315: 77-81.
4. Martin MA, Bock JM, Pfaller MA, Wenzel RP. Respiratory syncytial virus infections in adult bone marrow transplant recipients. Lancet 1988; 1: 1396-1397.
5. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 1989; 4: 35-40.
6. Sica S, Leone G, Marra R et al. Respiratory syncytial virus infection in bone marrow transplantation: a case report. Haematologica 1990; 75: 184-186.
7. Englund JA, Anderson LJ, Rhame RS. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 1991; 29: 115-119.
8. Takimoto CH, Cram DL, Root RK. Respiratory syncytial virus infections on an adult medical ward. Arch Intern Med 1991; 151: 706-708.
9. Harrington RD, Hooton TM, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987-993.
10. Win N, Mitchell D, Pugh S, Russell NH. Successful therapy with ribavirin of late onset respiratory syncytial virus pneumonitis complicating allogeneic bone marrow transplantation. Clin Lab Haematol 1992; 14: 29-32.
11. Fouillard L, Mouthon L, Laporte JP et al. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplant 1992; 9: 97-100.
12. Hall CB, McBride JT, Walsh EE et al. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. A randomized double-blind study. New Engl J Med 1983; 308: 1443-1447.
13. Hertz MI, Englund JA, Snover D et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 1989; 68: 269-281.
14. Prince GA, Hemming VG, Horswood RL, Channock RM. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cottom rat. Virus Res 1985; 3: 193-206.
15. Hemming VG, Prince GA, Horswood RL et al. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis 1985; 152: 1083-1087.
16. Siber GR, Leszczynski J, Pena-Cruz V et al. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis 1992: 165: 456-463.
17. Groothuis JR, Simoes EA, Levin MJ et al. Prophylactic administration of respiratory syncytial virus immune globulin to high risk infants and young children. New Engl J Med 1993; 329: 1524-1530.
18. Soiffer RJ, Murray C, Maunch P et al. Prevention of graft-versus-host disease by selective depletion of CD6 positive T lymphocytes from donor bone marrow. J Clin Oncol 1992; 10: 1191-1200.
19. Chao NJ, Duncan SR, Long GD et al. Corticosteroid therapy for diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Ann Intern Med 1991; 114: 145-146.
20. Rennard SI, Basset G, Lecossier D et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 1986; 60: 532-538.
21. Siber GR, Leombruno D, Leszczynski J et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis 1994; 169: 1368-1373.
22. Ottolini MG, Prince GA, Darnell MR et al. Immunoprophylaxis and immunotherapy are effective against respiratory syncytial virus infection in immunosuppressed cotton rats. Pediatr Res 1993; 33 178 abstr. 1048.
23. Gruber WC, Wilson SZ, Throop BJ, Wyde PR. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Pediatr Res 1987; 21: 270-274.
24. Whimbey E, Champlin R, Couch R et al. An outbreak of respiratory syncytial virus disease among hospitalized adult bone marrow transplant recipients: combination therapy with aerosolized ribavirin and IVIG for RSV pneumonia. Blood 1993; suppl. 425.
25. Taylor G, Furze J, Tempest PR et al. Humanized monoclonal antibody to respiratory syncytial virus. Lancet 1991; 337: 1411-1412.
26. Prince GA, Hemming VG, Horswood RL et al. Mechanism of antibody-mediated viral clearance in immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol 1990; 64: 3091-3092.
27. Hubbard RC, Brantly ML, Sellers SE et al. Anti neutrophilelastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 1989; 3: 206-212.
28. Hubbard RC, McElvaney NG, Birrer P et al. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. New Engl J Med 1992; 326: 812-815.
29. Hemming VG, Prince GA, London WT et al. Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys. Antimicrob Agents Chemother 1988; 32: 1269-1270.
30. Prince GA, Hemming VG, Horswood RL et al. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol 1987; 61: 1851-1854.